Skip to content

REVELATION BIOSCIENCES, INC.

REVB REVBW

CIK 0001810560

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$9.41M
+40.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$36.83
+97.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$10.61M
Q1 May 2026
Cash
$14.11M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
3.91M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings